HighMark Wealth Management’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-220
| Closed | -$2.66K | – | 621 |
|
|
2024
Q2 | $2.66K | Hold |
220
| – | – | ﹤0.01% | 448 |
|
|
2024
Q1 | $3.58K | Hold |
220
| – | – | ﹤0.01% | 402 |
|
|
2023
Q4 | $1.5K | Hold |
220
| – | – | ﹤0.01% | 486 |
|
|
2023
Q3 | $1.2K | Hold |
220
| – | – | ﹤0.01% | 490 |
|
|
2023
Q2 | $1.49K | Hold |
220
| – | – | ﹤0.01% | 479 |
|
|
2023
Q1 | $1.1K | Hold |
220
| – | – | ﹤0.01% | 535 |
|
|
2022
Q4 | $1.07K | Sell |
220
-500
| -69% | -$2.44K | ﹤0.01% | 470 |
|
|
2022
Q3 | $10K | Hold |
720
| – | – | 0.01% | 253 |
|
|
2022
Q2 | $11K | Hold |
720
| – | – | 0.01% | 239 |
|
|
2022
Q1 | $9K | Sell |
720
-150
| -17% | -$1.88K | 0.01% | 290 |
|
|
2021
Q4 | $14K | Sell |
870
-233
| -21% | -$3.75K | 0.01% | 219 |
|
|
2021
Q3 | $31K | Sell |
1,103
-178
| -14% | -$5K | 0.02% | 147 |
|
|
2021
Q2 | $43K | Buy |
1,281
+930
| +265% | +$31.2K | 0.03% | 129 |
|
|
2021
Q1 | $11K | Sell |
351
-30
| -8% | -$940 | 0.01% | 227 |
|
|
2020
Q4 | $19K | Sell |
381
-1,899
| -83% | -$94.7K | 0.02% | 167 |
|
|
2020
Q3 | $88K | Buy |
2,280
+2,041
| +854% | +$78.8K | 0.08% | 69 |
|
|
2020
Q2 | $10K | Buy |
+239
| New | +$10K | 0.01% | 205 |
|